The majority of FRDA patients (98%) carries an expansion of a GAA•TTC repeat in the first intron of the Frataxin (FXN) gene on both alleles, whereas the rest (2%) has an expansion on one allele and a point mutation or deletion on the other [10]. The gene discussed is FXN; the disease is Friedreich ataxia.